1. Dopamine 1 receptor agonists with selectiviy over D2 receptor
Tools: Homology model, Pharmacophore model, Docking, selectivity by pharmacophore model.
DOI: 10.1002/cmdc.201100546
2. mGluR5 receptor negative nanomolar modulator

Tools: Artificial Neural Network (345 active and 155774 inactive compounds).
DOI: 10.1002/cmdc.201100510
3. Otimization of the omeprazole-based inhibitors of CYP2C19
Tools: pharmacophore, homology model
DOI: 10.1021/jm201346g
4. Inhibitors of Eg5 mitotic kinesin
Tools: Pharmacophore search following structure-based virtual screening of 700 000 compounds database. 3 found hits.
DOI: 10.1021/jm201290v
5. Inhibitors of ATP binding cassette transporter ABCC5
Tools: Homology model, structure-based virtual screening. 11 found hits.DOI: 10.1021/jm2014666
6. Myotonic Dystrophy Type 1 RNA inhibitors
Tools: shape chemical similarity (ROCS), substructural search (RNA motif).
DOI: 10.1021/ja210088v
Tools: homology model, structure-based virtual screening (Glide), Biophysical Mapping
DOI: 10.1021/jm201455y
After finishing I stumble upon excelent examples from Blue Dolphin Discovery. Take a look at them also.




Thanks for posting this CADD success stories. I was reading an article about how were new medicines discovered and there was only one CADD success story mentioned there: http://www.nature.com/nrd/journal/v10/n7/full/nrd3480.html
ReplyDeleteThis list of CADD success stories is definitely needed and well appreciated.
It's only just arrieved stories, and of course not aprroved drugs.
DeleteVery nice and useful post!
ReplyDeleteThank's. I will continue to make such kind of resume.
Deleteinclude story of Anti influenza A - Zamanivir. based on natural ligand dockings, they made 2 derivative inhibitors, the 2nd of which was all it took to get a drug good enough for FDA approval ! just 2 drugs compared to hundreds which is normal.
ReplyDelete